Boston Lighthouse Innovations is a biotechnology startup that aims to accelerate clinical genomics through its next-generation solution suite. Founded in 2017, the company collaborates with Mass General Hospital's Center for Integrated Diagnostics to establish clinical next-generation sequencing labs globally. Boston Lighthouse Innovations' offering encompasses a clinical processing and reporting workflow for patient diagnostics. While the details of its last investment and investors are not available, the company's endeavor in the field of clinical genomics holds promise for the biotechnology industry.
There is no investment information
No recent news or press coverage available for Boston Lighthouse Innovations.